Additional Proxy Soliciting Materials (definitive) (defa14a)
May 11 2017 - 4:10PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
(RULE
14a-101)
INFORMATION
REQUIRED IN PROXY STATEMENT
SCHEDULE
14A INFORMATION
Proxy
Statement Pursuant to Section 14(a) of the
Securities
Exchange Act of 1934
(Amendment
No. )
Filed
by the Registrant [X]
Filed
by a Party other than the Registrant [ ]
Check
the appropriate box:
[ ]
|
Preliminary
Proxy Statement
|
|
|
[ ]
|
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
[ ]
|
Definitive
Proxy Statement
|
|
|
[X]
|
Definitive
Additional Materials
|
|
|
[ ]
|
Soliciting
Material Pursuant to §240.14a-12
|
VBI
VACCINES INC.
(Name
of Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment
of Filing Fee (Check the appropriate box):
[X]
|
No
fee required.
|
|
|
[ ]
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
1.
|
Title
of each class of securities to which transaction applies:
|
|
|
|
|
2.
|
Aggregate
number of securities to which transaction applies:
|
|
|
|
|
3.
|
Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined):
|
|
|
|
|
4.
|
Proposed
maximum aggregate value of transaction:
|
|
|
|
|
5.
|
Total
fee paid:
|
|
|
|
[ ]
|
Fee
paid previously with preliminary materials:
|
|
|
|
[ ]
|
Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date
of its filing.
|
|
|
|
1.
|
Amount
previously paid:
|
|
|
|
|
2.
|
Form,
Schedule or Registration Statement No.:
|
|
|
|
|
3.
|
Filing
Party:
|
|
|
|
|
4.
|
Date
Filed:
|
NOTICE
OF INTERNET AVAILABILITY OF PROXY MATERIALS
The
2017 Annual General and Special Meeting of Shareholders of
VBI
Vaccines Inc.
(the
“Company”)
Date:
Time:
Place:
|
Thursday, June 22, 2017
1:00 pm. (Eastern Time)
Boston Marriott Cambridge
50 Broadway
Cambridge, Massachusetts 02142
|
PROXY
STATEMENT AND 2016 ANNUAL REPORT ON FORM 10-K ARE AVAILABLE AT:
www.materials.proxyvote.com/91822J
Important
Notice Regarding the Availability of Proxy Materials
for the Shareholder Meeting To Be Held on June 22, 2017:
This
communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage
you to access and review all of the important information contained in the proxy materials before voting.
AGENDA
1.
|
Election
of Directors
: to elect the below nominees as directors to hold office until the next annual meeting of shareholders. See
“Proposal 1 - Election of Directors” in the Company’s proxy statement dated May 11, 2017 (the “
Proxy
Statement
”) for details.
|
01)
Jeff Baxter
|
05)
Adam Logal
|
02)
Steven Gillis
|
06)
Scott Requadt
|
03)
Sam Chawla
|
07)
Steven Rubin
|
04)
Michel De Wilde
|
|
2.
|
Executive
Compensation
: to approve, on an advisory basis, the frequency of holding an advisory vote on executive compensation. See
“Proposal 2 - Approval, on an Advisory Basis, of the Frequency of Holding an Advisory Vote on our Executive Compensation”
in the Proxy Statement for details.
|
|
|
3.
|
Named
Executive Officer Compensation:
to approve, on an advisory basis, the compensation of our named executive officers. See
“Proposal 3 - Approval on an Advisory Basis, of the Compensation of our Named Executive Officers” in the Proxy
Statement for details.
|
|
|
4.
|
Appointment
of Accounting Firm:
to approve the appointment of EisnerAmper LLP as our independent registered public accounting firm
until the next annual meeting of shareholders and remuneration to be set by the Audit Committee of the Board of Directors.
See “Proposal 4 - Approval of Appointment of Independent Registered Public Accounting Firm and Enumeration to be set
by the Audit Committee of the Board of Directors” in the Proxy Statement for details.
|
|
|
5.
|
Ratify
and Confirm Common Share Issuances
: to ratify and confirm common share issuances to certain Company consultants. See “Proposal
5 - Common Share Issuances to Consultants” in the Proxy Statement for details.
|
|
|
6.
|
Other
Business
: To transact such other business as may properly come before the Annual Meeting or any adjournment or adjournments
thereof.
|
Notice-and-access
:
This Notice of Internet Availability is prepared under the notice-and-access rules under National Instrument 54-101
Communication
with Beneficial Owners of Securities of a Reporting Issuer
and Rule 14a-16 of the Securities Exchange Act of 1934, as amended.
Notice-and-access is a set of rules for reducing the volume of materials that must be physically mailed to shareholders by allowing
issuers to post the Proxy Statement and additional materials online. Materials may be delivered electronically to shareholders.
Please call the Company toll free at
1-855-887-2244
if you have any questions about notice-and-access.
Proxy
Statement and Annual Report on Form 10-K
: The Proxy Statement and the Annual Report on Form 10-K for the year ended December
31, 2016 are available at
www.materials.proxyvote.com/91822J
, the Company’s profile on SEDAR at www.sedar.com, and
the Company’s EDGAR profile at www.sec.gov/edgar. Shareholders are reminded to review these online materials before voting.
If
you want to receive a paper or e-mail copy of these documents, you must request one. There is no charge to you for requesting
a copy. Please make your request for a copy as instructed below on or before May 24, 2016 to facilitate timely delivery.
To
request a paper copy of these items:
|
●
|
Call
our toll-free number — 1-877-907-7643; or
|
|
|
|
|
●
|
Visit
our website at www.proxyvote.com.
|
Please
clearly identify the items you are requesting; VBI Vaccines Inc., and your name along with the Control Number located in the lower
right hand corner of this notice and the name and address to which the materials should be mailed.
Proxy
:
Registered
holders:
This proxy must be received by Computershare Trust Company of Canada, 100 University Avenue, 8
th
Floor,
Toronto, Ontario, M5J 2Y1, Attention: Proxy Department by 1:00 p.m. (Eastern Time) on June 20, 2017.
Non-registered
holders:
Use the voting instruction form provided by your intermediary (bank, trust company or broker) and return it as early
as practicable to ensure that it is transmitted on time. It must be received by your intermediary with sufficient time for them
to file a proxy by the deadline noted above.
Voting
:
Registered
holders:
You must be a registered holder of common shares of the Company at the close of business on May 4, 2017 to vote.
You may vote in person or by proxy. A proxy need not be a shareholder. You can vote by mail by requesting a paper copy of the
materials, which will include a proxy card.
Vote
by Internet:
If you are a registered shareholder, you may vote by internet by following the instructions at www.investorvote.com.
Vote
by Telephone:
If you are a registered shareholder who lives in the United States or Canada, you may request a paper proxy
card from the Company by following the procedures set forth above, and submit proxies by telephone by following the “Vote
by Telephone” instructions on the proxy card. If you are a beneficial owner of common shares held in street name, please
check the voting instructions in the notice provided by your broker, bank or other intermediary for telephone voting availability.
Non-registered
holders:
You may vote or appoint a proxy using the voting instruction form provided to your intermediary, which will then
submit your vote or proxy appointment to the Company.
Further
information on voting can be found under the headings “How Can I Vote my Common Shares Without Attending the Annual Meeting”
and “What is the Difference Between Holding Common Shares as a Shareholder of Record or as a Beneficial Owner?” in
the Proxy Statement.
For
directions to attend the meeting in person, please call the Company’s investor relations department at (617) 830-3031.
Cambridge,
MA
|
BY
ORDER OF THE BOARD
|
May
11, 2017
|
(signed)
Jeff Baxter
|
|
Director,
President, and Chief Executive Officer
|
VBI Vaccines (NASDAQ:VBIV)
Historical Stock Chart
From Mar 2024 to Apr 2024
VBI Vaccines (NASDAQ:VBIV)
Historical Stock Chart
From Apr 2023 to Apr 2024